Left ventricular thrombi after short-term high-dose anticoagulants in acute myocardial infarction

K A Johannessen1, J E Nordrehaug, G von der Lippe

  • 1Medical Department, Diakonissehjemmet Hospital, Bergen, Norway.

European Heart Journal
|September 1, 1987
PubMed

Insights

Short-term anticoagulation after anterior myocardial infarction may lead to rapid left ventricular thrombi development. These thrombi can cause stroke, especially with persistent apical akinesis.

Area of Science:

  • Cardiology
  • Thrombosis Research

Background:

  • Left ventricular thrombi (LVT) are a complication of anterior acute myocardial infarction (AMI).
  • The impact of short-term, high-dose anticoagulation on LVT formation post-AMI requires investigation.

Purpose of the Study:

  • To assess the effect of short-term, high-dose anticoagulation on LVT occurrence after first anterior wall AMI.
  • To evaluate the relationship between LVT, subsequent embolic events, and echocardiographic findings.

Main Methods:

  • A randomized study comparing placebo (n=21) and high-dose anticoagulation (n=21) during the first 10 days post-AMI.
  • Cross-sectional echocardiography at 10 days, 1.3, and 6 months post-infarction.
  • Analysis of LVT predictors (apical akinesis) and embolic complications (stroke).

Main Results:

  • No LVT detected at 10 days in the anticoagulation group; 7/21 in placebo group.
  • LVT developed in 6/21 patients in the anticoagulation group by 1 month.
  • LVT resolved with warfarin but recurred in 5/12 patients after discontinuation.
  • Apical akinesis predicted LVT (100% sensitivity, 72.2% specificity).
  • Stroke occurred in 3/13 patients with LVT versus 0/11 without (P=0.025).

Conclusions:

  • Short-term anticoagulation cessation in anterior AMI can lead to rapid LVT development.
  • Persisting apical akinesis is a key predictor for LVT formation post-AMI.
  • LVT pose an embolic risk, highlighting the need for vigilant monitoring and management.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...